ITNS E-Update
February 23, 2009

Dear Colleagues:

Cytomegalovirus (CMV) infection is an important cause of morbidity and mortality in recipients of hematopoietic stem cell transplant (HSCT) and solid organ transplant (SOT). Despite significant progress in elucidating the pathophysiology of CMV infection in transplant recipients, diagnostic and therapeutic challenges remain.

The online, self-study program entitled CMV Infection in Transplant Recipients: Clinical Cases and Expert Opinion is designed to assist physicians, pharmacists, nurses, and other infectious disease specialists in understanding how to prevent and treat CMV disease.

To access this online activity,
please log on to www.RMEI.com/CMV053

Sincerely,

Sherri Kramer, MD
Director, Medical Affairs
Robert Michael Educational Institute LLC